"The Joe Lueken Cancer Center in Bemidji, MN provides a patient-centered home for healing. We are the region’s largest medical facility offering comprehensive cancer and blood disorder care."

During the past decade, Sanford Joe Lueken Cancer Center conducted 151 clinical trials. In the 10-year time frame, 151 clinical trials started and 56 clinical trials were completed, i.e. on average, 37.1% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 42 clinical trials were completed. i.e. 61.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanford Joe Lueken Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 100 trials, followed by "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "SWOG Cancer Research Network" with 18 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanford Joe Lueken Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Sanford Joe Lueken Cancer Center" are "Stage IV Lung Cancer AJCC v8" (10 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (8 trials), "Recurrent Fallopian Tube Carcinoma" (8 trials) and "Recurrent Primary Peritoneal Carcinoma" (8 trials). Many other conditions were trialed in "Sanford Joe Lueken Cancer Center" in a lesser frequency.

Most popular intervention types in "Sanford Joe Lueken Cancer Center" are "Drug" (143 trials), "Other" (125 trials), "Biological" (74 trials), "Procedure" (60 trials) and "Radiation" (48 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (66 trials), "Laboratory Biomarker Analysis" (53 trials), "Questionnaire Administration" (42 trials), "Computed Tomography" (33 trials) and "Carboplatin" (30 trials). Other intervention names were less common.

The vast majority of trials in "Sanford Joe Lueken Cancer Center" are 153 trials for "All" genders, 30 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Sanford Joe Lueken Cancer Center". undefined are not yet recruiting, 65 are recruiting, 96 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Sanford Joe Lueken Cancer Center, 7 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sanford Joe Lueken Cancer Center, 4 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 107 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".